Monday, February 09, 2026 | 04:12 AM ISTहिंदी में पढें
Medicamen Biotech Ltd
Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.
03:49 PM, 4th Feb 2026
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the unaudited consolidated and standalone financial results of the Company for the quarter and nine months ended on December 31 2025.